|
MechanismCB1 inverse agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Patheon Softgels, Inc. (North Carolina)
0 Patents (Medical) associated with Patheon Softgels, Inc. (North Carolina)
100 Deals associated with Patheon Softgels, Inc. (North Carolina)
100 Translational Medicine associated with Patheon Softgels, Inc. (North Carolina)